Back to Search
Start Over
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
- Source :
-
European journal of medicinal chemistry [Eur J Med Chem] 2012 Apr; Vol. 50, pp. 90-101. Date of Electronic Publication: 2012 Jan 30. - Publication Year :
- 2012
-
Abstract
- We report new examples of a series of losartan-hydrocaffeic hybrids that bear novel ester, amide and amine linkers. These compounds were made by linking hydrocaffeic acid to the side chain of losartan at the C-5 position of the imidazole ring through different strategies. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect and have increased antioxidant ability. Most of them reduced arterial pressure in rats better or as much as losartan.<br /> (Copyright © 2012 Elsevier Masson SAS. All rights reserved.)
- Subjects :
- Amides chemistry
Amides metabolism
Amines chemistry
Amines metabolism
Angiotensin II pharmacology
Animals
Aorta, Thoracic cytology
Aorta, Thoracic drug effects
Caffeic Acids pharmacology
Cells, Cultured
Esters chemistry
Esters metabolism
Hypertension drug therapy
Losartan pharmacology
Male
Molecular Structure
Muscle, Smooth, Vascular cytology
Muscle, Smooth, Vascular drug effects
Rats
Rats, Wistar
Structure-Activity Relationship
Vasoconstrictor Agents pharmacology
Antihypertensive Agents chemical synthesis
Antihypertensive Agents pharmacology
Antioxidants chemical synthesis
Antioxidants pharmacology
Caffeic Acids chemistry
Losartan chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1768-3254
- Volume :
- 50
- Database :
- MEDLINE
- Journal :
- European journal of medicinal chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 22336384
- Full Text :
- https://doi.org/10.1016/j.ejmech.2012.01.043